ClinicalTrials.govpublic full text
Specifying the Anti-inflammatory Effects of Ziltivekimab
atherosclerosis, inflammation, dotatate, ziltivekimab, monocytes, ccta, pet/ct, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914588
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.